NEW YORK (GenomeWeb News) – Beckman Coulter today said that it has formed Beckman Coulter Genomics, which combines the operations of its Agencourt Bioscience business with Cogenics, a firm it recently purchased.

Orange County, Calif.-based Beckman said that the new company will offer researchers a "single genomic services resource with expanded global capabilities." It will offer a variety of services including sequencing, sample preparation, genotyping, gene expression, biological efficiency and safety testing, and support for regulatory compliance including CLIA.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.